SWI/SNF complexes containing brahma Brahma-related gene 1 play distinct roles in smooth muscle development

Molecular and Cellular Biology

Volumn 31, Issue 13, 2011, Pages 2618-2631

  Zhang, Min ^a   Chen, Meng ^a   Kim, Ju Ryoung ^a   Zhou, Jiliang ^a,c   Jones, Rebekah E ^a   Tune, Johnathan D ^a   Kassab, Ghassan S ^a   Metzger, Daniel ^b   Ahlfeld, Shawn ^a   Conway, Simon J ^a   Herring, B Paul ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^c ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRG1 PROTEIN; BRM PROTEIN; CONTRACTILE PROTEIN; CRE RECOMBINASE; MYOSIN HEAVY CHAIN; PROTEIN SWI; TRANSCRIPTION FACTOR SNF;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; COMPLEX FORMATION; FEMALE; IN VIVO STUDY; INTESTINE MUSCLE; KNOCKOUT MOUSE; MALE; MOUSE; MUSCLE CONTRACTILITY; MUSCLE DEVELOPMENT; NONHUMAN; PATENT DUCTUS ARTERIOSUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE; VASCULAR SMOOTH MUSCLE;

ANIMALS; DNA HELICASES; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, DEVELOPMENTAL; INTESTINAL PSEUDO-OBSTRUCTION; INTESTINES; MICE; MICE, KNOCKOUT; MUSCLE DEVELOPMENT; MUSCLE, SMOOTH; MUTATION; NUCLEAR PROTEINS; STOMACH; TRANSCRIPTION FACTORS;

MAMMALIA; MUS;

EID: 79959486572     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01338-10     Document Type: Article

References (34)

1. Bultman, S., et al. 2000. A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. Mol. Cell 6:1287-1295.
2. Bultman, S. J., et al. 2008. Characterization of mammary tumors from Brg1 heterozygous mice. Oncogene 27:460-468.
3. Cao, Y., et al. 2010. Epigenetic mechanisms modulate thyroid transcription factor 1-mediated transcription of the surfactant protein B gene. J. Biol. Chem. 285:2152-2164.
4. Chang, D. F., N. S. Belaguli, J. Chang, and R. J. Schwartz. 2007. LIM-only protein, CRP2, switched on smooth muscle gene activity in adult cardiac myocytes. Proc. Natl. Acad. Sci. U. S. A. 104:157-162.
5. Chi, T. H., et al. 2003. Sequential roles of Brg, the ATPase subunit of BAF chromatin remodeling complexes, in thymocyte development. Immunity 19: 169-182.
6. Conway, S. J., A. Kruzynska-Frejtag, P. L. Kneer, M. Machnicki, and S. V. Koushik. 2003. What cardiovascular defect does my prenatal mouse mutant have, and why? Genesis 35:1-21.
7. de Lange, W. J., C. M. Halabi, A. M. Beyer, and C. D. Sigmund. 2008. Germ line activation of the Tie2 and SMMHC promoters causes noncell-specific deletion of floxed alleles. Physiol. Genomics 35:1-4.
8. de la Serna, I. L., Y. Ohkawa, and A. N. Imbalzano. 2006. Chromatin remodelling in mammalian differentiation: lessons from ATP-dependent remodellers. Nat. Rev. Genet. 7:461-473.
9. Dick, G. M., et al. 2006. Resistin impairs endothelium-dependent dilation to bradykinin, but not acetylcholine, in the coronary circulation. Am. J. Physiol. Heart Circ. Physiol. 291:H2997-H3002.
10. Gallagher, P. J., and B. P. Herring. 1991. The carboxyl terminus of the smooth muscle myosin light chain kinase is expressed as an independent protein, telokin. J. Biol. Chem. 266:23945-23952.
11. Gebuhr, T. C. 2003. The role of Brg1, a catalytic subunit of mammalian chromatin-remodeling complexes, in T cell development. J. Exp. Med. 198: 1937-1949.
12. Griffin, C. T., J. Brennan, and T. Magnuson. 2008. The chromatin-remodeling enzyme BRG1 plays an essential role in primitive erythropoiesis and vascular development. Development 135:493-500.
13. Hang, C. T., et al. 2010. Chromatin regulation by Brg1 underlies heart muscle development and disease. Nature 466:62-67.
14. Hendricks, K. B., F. Shanahan, and E. Lees. 2004. Role for BRG1 in cell cycle control and tumor suppression. Mol. Cell. Biol. 24:362-376.
15. Herring, B. P., G. E. Lyons, A. M. Hoggatt, and P. J. Gallagher. 2001. Telokin expression is restricted to smooth muscle tissues during mouse development. Am. J. Physiol. Cell Physiol. 280:C12-C21.
16. Indra, A. K., et al. 2005. Temporally controlled targeted somatic mutagenesis in embryonic surface ectoderm and fetal epidermal keratinocytes unveils two distinct developmental functions of BRG1 in limb morphogenesis and skin barrier formation. Development 132:4533-4544.
17. Kang, H., K. Cui, and K. Zhao. 2004. BRG1 controls the activity of the retinoblastoma protein via regulation of p21CIP1/WAF1/SDI. Mol. Cell. Biol. 24:1188-1199.
18. Knudson, J. D., et al. 2005. Leptin receptors are expressed in coronary arteries, and hyperleptinemia causes significant coronary endothelial dysfunction. Am. J. Physiol. Heart Circ. Physiol. 289:H48-H56.
19. Lu, X., and G. S. Kassab. 2007. Vasoactivity of blood vessels using a novel isovolumic myograph. Ann. Biomed. Eng. 35:356-366.
20. Matsumoto, S., et al. 2006. Brg1 is required for murine neural stem cell maintenance and gliogenesis. Dev. Biol. 289:372-383.
21. Muchardt, C., and M. Yaniv. 2001. When the SWI/SNF complex remodels...the cell cycle. Oncogene 20:3067-3075.
22. Naidu, S. R., I. M. Love, A. N. Imbalzano, S. R. Grossman, and E. J. Androphy. 2009. The SWI/SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cells. Oncogene 28:2492-2501.
23. Ose, T., et al. 2007. Reg I-knockout mice reveal its role in regulation of cell growth that is required in generation and maintenance of the villous structure of small intestine. Oncogene 26:349-359.
24. Reyes, J. C., et al. 1998. Altered control of cellular proliferation in the absence of mammalian brahma (SNF2alpha). EMBO J. 17:6979-6991.
25. Roberts, C. W., S. A. Galusha, M. E. McMenamin, C. D. Fletcher, and S. H. Orkin. 2000. Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice. Proc. Natl. Acad. Sci. U. S. A. 97:13796-13800.
26. Stankunas, K., et al. 2008. Endocardial Brg1 represses ADAMTS1 to maintain the microenvironment for myocardial morphogenesis. Dev. Cell 14:298-311.
27. Sumi-Ichinose, C., H. Ichinose, D. Metzger, and P. Chambon. 1997. SNF2beta-BRG1 is essential for the viability of F9 murine embryonal carcinoma cells. Mol. Cell. Biol. 17:5976-5986.
28. Touw, K., A. M. Hoggatt, G. Simon, and B. P. Herring. 2007. Hprt-targeted transgenes provide new insights into smooth muscle-restricted promoter activity. Am. J. Physiol. Cell Physiol. 292:C1024-C1032.
29. Wang, L., et al. 2005. The BRG1- and hBRM-associated factor BAF57 induces apoptosis by stimulating expression of the cylindromatosis tumor suppressor gene. Mol. Cell. Biol. 25:7953-7965.
30. Weaver, T. E., and J. J. Conkright. 2001. Function of surfactant proteins B and C. Annu. Rev. Physiol. 63:555-578.
31. Wert, S. E., J. A. Whitsett, and L. M. Nogee. 2009. Genetic disorders of surfactant dysfunction. Pediatr. Dev. Pathol. 12:253-274.
32. Xin, H. B., K. Y. Deng, M. Rishniw, G. Ji, and M. I. Kotlikoff. 2002. Smooth muscle expression of Cre recombinase and eGFP in transgenic mice. Physiol. Genomics 10:211-215.
33. Zhang, M., H. Fang, J. Zhou, and B. P. Herring. 2007. A novel role of Brg1 in the regulation of SRF/MRTFA-dependent smooth muscle-specific gene expression. J. Biol. Chem. 282:25708-25716.
34. Zhou, J., et al. 2009. The SWI/SNF chromatin remodeling complex regulates myocardin-induced smooth muscle-specific gene expression. Arterioscler. Thromb. Vasc. Biol. 29:921-928.